Literature DB >> 20463066

Genetically engineered, biarsenically labeled influenza virus allows visualization of viral NS1 protein in living cells.

Yang Li1, Xinya Lu, Junwei Li, Nathalie Bérubé, Kerri-Lane Giest, Qiang Liu, Deborah H Anderson, Yan Zhou.   

Abstract

Real-time fluorescence imaging of viral proteins in living cells provides a valuable means to study virus-host interactions. The challenge of generating replication-competent fluorescent influenza A virus is that the segmented genome does not allow fusion of a fluorescent protein gene to any viral gene. Here, we introduced the tetracysteine (TC) biarsenical labeling system into influenza virus in order to fluorescently label viral protein in the virus life cycle. We generated infectious influenza A viruses bearing a small TC tag (CCPGCC) in the loop/linker regions of the NS1 proteins. In the background of A/Puerto Rico/8/34 (H1N1) (PR8) virus, the TC tag can be inserted into NS1 after amino acid 52 (AA52) (PR8-410), AA79 (PR8-412), or AA102 (PR8-413) or the TC tag can be inserted and replace amino acids 79 to 84 (AA79-84) (PR8-411). Although PR8-410, PR8-411, and PR8-412 viruses are attenuated than the wild-type (WT) virus to some extent in multiple-cycle infection, their growth potential is similar to that of the WT virus during a single cycle of infection, and their NS1 subcellular localization and viral protein synthesis rate are quite similar to those of the WT virus. Furthermore, labeling with membrane-permeable biarsenical dye resulted in fluorescent NS1 protein in the context of virus infection. We could exploit this strategy on NS1 protein of A/Texas/36/91 (H1N1) (Tx91) by successfully rescuing a TC-tagged virus, Tx91-445, which carries the TC tag replacement of AA79-84. The infectivity of Tx91-445 virus was similar to that of WT Tx91 during multiple cycles of replication and a single cycle of replication. The NS1 protein derived from Tx91-445 can be fluorescently labeled in living cells. Finally, with biarsenical labeling, the engineered replication-competent virus allowed us to visualize NS1 protein nuclear import in virus-infected cells in real time.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20463066      PMCID: PMC2898259          DOI: 10.1128/JVI.00203-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Visualizing infection of individual influenza viruses.

Authors:  Melike Lakadamyali; Michael J Rust; Hazen P Babcock; Xiaowei Zhuang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-25       Impact factor: 11.205

2.  Phosphorylated protein component present in influenza virions.

Authors:  M L Privalsky; E E Penhoet
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

3.  A DNA transfection system for generation of influenza A virus from eight plasmids.

Authors:  E Hoffmann; G Neumann; Y Kawaoka; G Hobom; R G Webster
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

4.  New biarsenical ligands and tetracysteine motifs for protein labeling in vitro and in vivo: synthesis and biological applications.

Authors:  Stephen R Adams; Robert E Campbell; Larry A Gross; Brent R Martin; Grant K Walkup; Yong Yao; Juan Llopis; Roger Y Tsien
Journal:  J Am Chem Soc       Date:  2002-05-29       Impact factor: 15.419

5.  Eight-plasmid system for rapid generation of influenza virus vaccines.

Authors:  Erich Hoffmann; Scott Krauss; Daniel Perez; Richard Webby; Robert G Webster
Journal:  Vaccine       Date:  2002-08-19       Impact factor: 3.641

6.  Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia.

Authors:  K S Li; Y Guan; J Wang; G J D Smith; K M Xu; L Duan; A P Rahardjo; P Puthavathana; C Buranathai; T D Nguyen; A T S Estoepangestie; A Chaisingh; P Auewarakul; H T Long; N T H Hanh; R J Webby; L L M Poon; H Chen; K F Shortridge; K Y Yuen; R G Webster; J S M Peiris
Journal:  Nature       Date:  2004-07-08       Impact factor: 49.962

7.  Epsin 1 is a cargo-specific adaptor for the clathrin-mediated endocytosis of the influenza virus.

Authors:  Chen Chen; Xiaowei Zhuang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-08       Impact factor: 11.205

Review 8.  The multifunctional NS1 protein of influenza A viruses.

Authors:  Benjamin G Hale; Richard E Randall; Juan Ortín; David Jackson
Journal:  J Gen Virol       Date:  2008-10       Impact factor: 3.891

9.  Structural basis for suppression of a host antiviral response by influenza A virus.

Authors:  Kalyan Das; Li-Chung Ma; Rong Xiao; Brian Radvansky; James Aramini; Li Zhao; Jesper Marklund; Rei-Lin Kuo; Karen Y Twu; Eddy Arnold; Robert M Krug; Gaetano T Montelione
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-25       Impact factor: 11.205

10.  Drosophila RNAi screen identifies host genes important for influenza virus replication.

Authors:  Linhui Hao; Akira Sakurai; Tokiko Watanabe; Ericka Sorensen; Chairul A Nidom; Michael A Newton; Paul Ahlquist; Yoshihiro Kawaoka
Journal:  Nature       Date:  2008-07-09       Impact factor: 49.962

View more
  21 in total

1.  Replication-competent influenza A virus that encodes a split-green fluorescent protein-tagged PB2 polymerase subunit allows live-cell imaging of the virus life cycle.

Authors:  Sergiy V Avilov; Dorothée Moisy; Sandie Munier; Oliver Schraidt; Nadia Naffakh; Stephen Cusack
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

2.  Low-Fidelity Assembly of Influenza A Virus Promotes Escape from Host Cells.

Authors:  Michael D Vahey; Daniel A Fletcher
Journal:  Cell       Date:  2018-11-29       Impact factor: 41.582

3.  The R35 residue of the influenza A virus NS1 protein has minimal effects on nuclear localization but alters virus replication through disrupting protein dimerization.

Authors:  Erin N Lalime; Andrew Pekosz
Journal:  Virology       Date:  2014-05-05       Impact factor: 3.616

4.  Identification of RNA helicase A as a cellular factor that interacts with influenza A virus NS1 protein and its role in the virus life cycle.

Authors:  Li Lin; Yang Li; Hyun-Mi Pyo; Xinya Lu; Sathya N Thulasi Raman; Qiang Liu; Earl G Brown; Yan Zhou
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

5.  Visualizing Influenza A Virus vRNA Replication.

Authors:  Ya-Fang Chiu; Yi-Wen Huang; Chi-Yuan Chen; Yu-Chia Chen; Yu-Nong Gong; Rei-Lin Kuo; Chung-Guei Huang; Shin-Ru Shih
Journal:  Front Microbiol       Date:  2022-06-06       Impact factor: 6.064

6.  p∆TubHA4C, a new versatile vector for constitutive expression in Drosophila.

Authors:  Yan Zhang; Stephanie Arcia; Barbara Perez; Pedro Fernandez-Funez; Diego E Rincon-Limas
Journal:  Mol Biol Rep       Date:  2013-05-17       Impact factor: 2.316

7.  Labeling of multiple HIV-1 proteins with the biarsenical-tetracysteine system.

Authors:  Cândida F Pereira; Paula C Ellenberg; Kate L Jones; Tara L Fernandez; Redmond P Smyth; David J Hawkes; Marcel Hijnen; Valérie Vivet-Boudou; Roland Marquet; Iain Johnson; Johnson Mak
Journal:  PLoS One       Date:  2011-02-11       Impact factor: 3.240

8.  Identification of adaptive mutations in the influenza A virus non-structural 1 gene that increase cytoplasmic localization and differentially regulate host gene expression.

Authors:  Nicole Forbes; Mohammed Selman; Martin Pelchat; Jian Jun Jia; Alain Stintzi; Earl G Brown
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

Review 9.  Engineering influenza viral vectors.

Authors:  Junwei Li; Maria T Arévalo; Mingtao Zeng
Journal:  Bioengineered       Date:  2012-08-24       Impact factor: 3.269

10.  Optimisations and Challenges Involved in the Creation of Various Bioluminescent and Fluorescent Influenza A Virus Strains for In Vitro and In Vivo Applications.

Authors:  Monique I Spronken; Kirsty R Short; Sander Herfst; Theo M Bestebroer; Vincent P Vaes; Barbara van der Hoeven; Abraham J Koster; Gert-Jan Kremers; Dana P Scott; Alexander P Gultyaev; Erin M Sorell; Miranda de Graaf; Montserrat Bárcena; Guus F Rimmelzwaan; Ron A Fouchier
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.